接种 ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生视网膜分支静脉阻塞。
Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.
机构信息
First Opthhalmology Department, "G.Gennimatas" Hospital, Athens, Greece.
National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Eur J Ophthalmol. 2023 Sep;33(5):NP121-NP123. doi: 10.1177/11206721221124651. Epub 2022 Sep 4.
PURPOSE
To present a case of branch retinal vein occlusion (BRVO) following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) Vaccine.
METHODS
Case report.
RESULTS
A 60-year old otherwise healthy Caucasian male, presented to the ophthalmology emergency clinic complaining of sudden, painless vision loss in his right eye of 24 h" duration. The patient had received Vaxveria seven days prior. The clinical and fundus examination of the right eye established the diagnosis of BRVO.
CONCLUSION
The present case descibes the occurrence of BRVO soon after the vaccination with the Oxford-AstraZeneca vaccine. The close temporal relationship between the BRVO incidence and the vaccination is reinforced by the lack of othe subjective cause to justify the episode.
目的
报告 1 例接种 ChAdOx1 nCoV-19（牛津-阿斯利康）疫苗后发生分支视网膜静脉阻塞（BRVO）的病例。
方法
病例报告。
结果
一名 60 岁的白人男性，既往健康，因右眼无痛性视力丧失 24 小时就诊于眼科急诊。患者在七天前接种了 Vaxveria。右眼的临床和眼底检查确立了 BRVO 的诊断。
结论
本病例描述了在接种牛津-阿斯利康疫苗后不久发生 BRVO 的情况。BRVO 发病与接种的时间密切相关，且没有其他主观原因可以解释这一事件，这进一步证实了两者之间的关联。
Zotero 插件